rs6818964
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_032217.5(ANKRD17):c.4402-2200G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_032217.5 intron
Scores
Clinical Significance
Conservation
Publications
- syndromic complex neurodevelopmental disorderInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- Chopra-Amiel-Gordon syndromeInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_032217.5. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ANKRD17 | TSL:5 MANE Select | c.4402-2200G>C | intron | N/A | ENSP00000351416.4 | O75179-1 | |||
| ANKRD17 | TSL:1 | c.4063-2200G>C | intron | N/A | ENSP00000427151.2 | O75179-7 | |||
| ANKRD17 | TSL:1 | c.4051-2200G>C | intron | N/A | ENSP00000453434.1 | H0YM23 |
Frequencies
GnomAD3 genomes AF: 0.0000143 AC: 2AN: 140178Hom.: 0 Cov.: 31 show subpopulations
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000143 AC: 2AN: 140178Hom.: 0 Cov.: 31 AF XY: 0.0000148 AC XY: 1AN XY: 67606 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.